tamoxifen ebewe 10mg tableta
ebewe pharma ges.m.b.h nfg.kg, unterach array - 1540 tamoxifen-citrÁt - tableta - 10mg - tamoxifen
tamoxifen ebewe 20mg tableta
ebewe pharma ges.m.b.h nfg.kg, unterach array - 1540 tamoxifen-citrÁt - tableta - 20mg - tamoxifen
rowachol enterosolventní měkká tobolka
rowa pharmaceuticals ltd., newtown, bantry array - 3825 alfa-pinen; 3826 beta-pinen; 3827 kamfen; 597 cineol; 3824 menthon; 11077 levomenthol; 3162 borneol - enterosolventní měkká tobolka - jinÁ lÉČiva k terapii onemocnĚnÍ ŽluČovÝch cest
rowachol perorální kapky, roztok
rowa pharmaceuticals ltd., newtown, bantry array - 3825 alfa-pinen; 3826 beta-pinen; 3827 kamfen; 597 cineol; 3824 menthon; 11077 levomenthol; 3162 borneol - perorální kapky, roztok - jinÁ lÉČiva k terapii onemocnĚnÍ ŽluČovÝch cest
rowatinex měkká tobolka
rowa pharmaceuticals ltd., newtown, bantry array - 3825 alfa-pinen; 3826 beta-pinen; 3827 kamfen; 597 cineol; 3829 fenchon; 3162 borneol; 3828 anethol - měkká tobolka - fytofarmaka a ŽivoČiŠnÉ produkty (ČeskÁ atc skupina)
rowatinex perorální kapky, roztok
rowa pharmaceuticals ltd., newtown, bantry array - 3825 alfa-pinen; 3826 beta-pinen; 3827 kamfen; 597 cineol; 3829 fenchon; 3162 borneol; 3828 anethol; 1608 panenskÝ olivovÝ olej - perorální kapky, roztok - fytofarmaka a ŽivoČiŠnÉ produkty (ČeskÁ atc skupina)
verzenios
eli lilly nederland b.v. - abemaciclib - neoplasmy prsů - antineoplastická činidla - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.
anastrozol mylan 1mg potahovaná tableta
mylan ireland limited, dublin array - 14074 anastrozol - potahovaná tableta - 1mg - anastrozol
exemestan mylan 25mg potahovaná tableta
mylan ireland limited, dublin array - 11194 exemestan - potahovaná tableta - 25mg - exemestan
letrozol teva pharma 2,5mg potahovaná tableta
teva pharma b.v., haarlem array - 13754 letrozol - potahovaná tableta - 2,5mg - letrozol